DABIGATRAN

UNII:	I0VM4M70GC
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₂₅N₇O₃
Preferred Substance Name:	DABIGATRAN
InChIKey:	YBSJFWOBGCMAKL-UHFFFAOYSA-N
GSRS Full Record:	I0VM4M70GC i

211914-51-1
.BETA.-ALANINE, N-((2-(((4-(AMINOIMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-
3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid
3-{[(2-{[(4-Carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl](pyridin-2-yl)amino}propanoic acid
BIBR 953 ZW
BIBR-953
BIBR-953-ZW
DABIGATRAN [MART.]
DABIGATRAN [MI]
DABIGATRAN [USAN]
DABIGATRAN [VANDF]
Dabigatran [WHO-DD]
N-((2-((P-AMIDINOANILINO)METHYL)-1-METHYL-5-BENZIMIDAZOLYL)CARBONYL)-N-2-PYRIDYL-.BETA.-ALANINE
PRADAXA (DABIGATRAN)
dabigatran [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DABIGATRAN

Synonyms and Mappings

Resources